MEDIOX

MEDIOX has been active since 1980 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €132,792 and a net result of -€6,017. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 68% of 9,597 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).